SCHEMBL1462891

SCHEMBL1462891

Cn1c(-c2ccccc2)nc2cc(O)ccc2c1=O

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.58
GAA P10253 2/20 0.54
KMT2A Q03164 2/20 0.54
MEN1 O00255 1/20 0.54
ALDH1A1 P00352 2/20 0.50
LMNA P02545 1/20 0.50
EGFR P00533 3/20 0.48
CASR P41180 2/20 0.48
POLB P06746 1/20 0.48
PARG Q86W56 1/20 0.47
HSD17B10 Q99714 1/20 0.46
ESR2 Q92731 1/20 0.46
BACE1 P56817 1/20 0.46
ADRA1A P35348 1/20 0.45
KCNH2 Q12809 1/20 0.45
HRH3 Q9Y5N1 1/20 0.45
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1462695 0.86 ESR1 (0.59) ESR1GAAKMT2AMEN1ALDH1A1
SCHEMBL12744507 0.85 KMT2A (0.52) GAAKMT2AMEN1ALDH1A1LMNA
SCHEMBL1463333 0.83 KMT2A (0.65) KMT2AMEN1ALDH1A1LMNACASR
SCHEMBL29764078 0.83 KMT2A (0.65) KMT2AMEN1ALDH1A1LMNACASR
SCHEMBL1464587 0.83 EGFR (0.67) KMT2AMEN1ALDH1A1LMNAEGFR
SCHEMBL1463663 0.81 KCNH2 (0.59) KMT2AMEN1ALDH1A1EGFRPOLB
SCHEMBL19359658 0.80 ESR1 (0.54) ESR1GAAKMT2AALDH1A1POLB
SCHEMBL2007293 0.78 CASR (0.51) GAAKMT2AMEN1ALDH1A1LMNA
SCHEMBL31277167 0.78 PARG (0.56) KMT2AMEN1ALDH1A1LMNAPARG
SCHEMBL1463696 0.78 KCNH2 (0.54) KMT2AMEN1ALDH1A1LMNAEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110071148-A1 COMPOUNDS AS THE ESTROGEN RELATED RECEPTORS MODULATORS AND THE USES THEREOF GUANGZHOU INSTITUTE OF BIOMEDICINE AND HEALTH, CHINESE ACADEMY OF SCIENCES (CN) 2011-03-24 US claimed
US-20110071148-A1 COMPOUNDS AS THE ESTROGEN RELATED RECEPTORS MODULATORS AND THE USES THEREOF GUANGZHOU INSTITUTE OF BIOMEDICINE AND HEALTH, CHINESE ACADEMY OF SCIENCES (CN) 2011-03-24 US disclosed
EP-2266962-A1 THE COMPOUNDS AS THE ESTROGEN RELATED RECEPTORS MODULATORS AND THE USES THEREOF Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences (CN) 2010-12-29 EP disclosed
CN-101531638-A Compounds useful as estrogen-related receptor modulators and uses thereof CHINESE ACADEMY OF SCIENCES GU 2009-09-16 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110071148-A1 COMPOUNDS AS THE ESTROGEN RELATED RECEPTORS MODULATORS AND THE USES THEREOF ESRRA, ESRRB, ESRRG ESR1 5/4885GAA 648/4885KMT2A 1845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.